STAAR Surgical Company (NDAQ:STAA) moved up $0.18, or 2.94%, to $6.31 today after Broadwood Capital disclosed a 9.5% stake in the company. The fund also commended the company on its substantial and ongoing improvements that came about after implementing Broadwood's governance reforms that were originally requested in April 2005. Notably, the fund also stated that because the company's increasing revenue growth and improving margins have not yet been reflected in its stock price, the fund may continue to oppose any proposed acquisition of the company at a price that does not represent a very large premium to its current market value. While the company is currently trading above enterprise value, the present value of future cash flows accounting for the recent revenue increases may demand a higher premium in the event of a buyout. Regardless, given Broadwood's confidence in the company, this may be a stock worth putting on the radar throughout the next few months!

Related Companies
Advanced Medical Optics, Inc. (EYE)
Bausch & Lomb Inc. (BOL)